in order to ascertain whether multiple myeloma patients resistant to one alkylating agent would respond to a second one , high-dose intermittent cyclophosphamide was administered to 12 patients showing resistance to melphalan and prednisone .
C0026764
multiple myeloma
C0010583
cyclophosphamide